Chief Executive Officer (CEO)

Dr. Khushbukhat Khan, a Cancer Geneticist and co-founder of BioinfoXpert, boasts a distinguished career marked by over three years of extensive engagement in oncology research and development, positioning her as a foremost authority in the field. Leveraging her exceptional expertise, she has been pivotal in driving the progress of biotechnology companies across the UK and USA, rendering two years of remote consultancy services that exemplify her impactful contributions.

Simultaneously, Dr. Khan holds the esteemed position of Project Lead for oncology pre-clinical and clinical trials at Trials360, a distinguished subsidiary of Hayat Pharmaceutical Consulting located in California, USA. Her academic foundation includes a Ph.D. earned from the esteemed National University of Sciences and Technology (NUST), one of Asia's premier institutions.

Her research, centered on oncogenic markers at gene and protein levels within the Pakistani population, explored their potential as vital prognostic and diagnostic tools. Furthermore, she delved into the realm of natural compound-based therapeutic strategies for breast cancer and hepatic cell carcinoma, unveiling promising alternatives to conventional chemotherapy.

Going beyond her remarkable research accomplishments, Dr. Khan is an ardent advocate for breast cancer awareness, channeling her passion by delivering impactful talks on Pakistani radio platforms. Her efforts in disseminating crucial information empower individuals to proactively navigate their health journey.

In recognition of her academic excellence, Dr. Khan was bestowed with the prestigious HEC indigenous Ph.D. fellowship in 2019. With an impressive track record, she has contributed substantially to the scientific landscape with over 40 influential papers published in esteemed scientific journals. Dr. Khushbukhat Khan continues to redefine the boundaries of cancer genetics and research, leaving an indelible mark on the field's advancement.